Multiple Sclerosis remains a global challenge.
There is still no effective diagnostic test and response to treatment is unpredictable. Patients continue to suffer and progress is limited.
The role of the immune system in attacking the nerves has been investigated. However a technology to truly characterise T cell activity has remained elusive until now.
Omniscope's proprietary T cell technology offers unprecedented insights into the dynamics of the immune response. As part of our responsibility to society we want to join forces with disease experts to accelerate research in the diagnosis of Multiple Sclerosis. Moreover, to predict patient response to therapy.
Three investigators will be awarded a fully funded T cell immunosequencing and analysis of retrospective cohorts. The top prize will also receive a EUR 10,000 research support grant and a feature on our website.
The deadline for submission is 29th October, 2023.
Together we can as: "Science is we all."
By submitting this form you consent to us emailing you occasionally about our products and services. You can unsubscribe at any time, and we will never share your email with third parties. Privacy Policy.
